Title: A 19-week, randomized, double-blind, multicenter, placebo-controlled safety study to evaluate the cognitive and neuropsychological effects of levetiracetam 20-60 mg/kg/day, divided into twice daily dosing, as adjunctive treatment in children 4-16 years old, with partial onset seizures.
Principal Investigator: Maria Sam, M.D.
Multi-site trial, observing the effects on cognition and behavior in children with partial onset epilepsy treated with Keppra vs placebo
Inclusion Criteria: Refractory partial onset epilepsy patients/age 4 to 16/ having 1 or more seizures per month/ suitable candidate for Keppra.
Epilepsy Completed
Contact: Nancy Buchheimer
336-716-3961
nbuchhe@wfubmc.edu
Sponsor: UCB Completed